Rune Labs

Executive Summary

Rune Labs is a precision neurology company leveraging wearable sensor data, patient-reported outcomes, and clinical analytics to improve care delivery and accelerate therapy development for neurodegenerative diseases. Initially focused on Parkinson's disease, the company's platform integrates multimodal data to provide actionable insights for clinicians and researchers. By combining AI-driven analytics with real-world evidence, Rune aims to enable earlier diagnosis, personalized treatment, and more efficient clinical trials. The company has announced plans to expand into multiple sclerosis, OCD, and essential tremor, broadening its addressable market. With a strong technological foundation and a clear focus on unmet needs in neurology, Rune Labs is positioned to become a key player in digital health and precision medicine.

Upcoming Catalysts (preview)

• Q3 2026Expansion into multiple sclerosis and OCD indications75% success
• Q2 2026Publication of key clinical validation study for Parkinson's platform80% success
• Q4 2026Strategic partnership with major pharma for clinical trial analytics65% success